Ping Liu Selected Research

Chronic Hepatitis B

1/2024	LiveBoost: A GB-based prediction system for liver fibrosis in chronic hepatitis B patients in China - A multi-center retrospective study.
11/2022	Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial.
1/2022	Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B.
10/2021	Serum sCD14 as a Biomarker for Significant Liver Inflammation in Chronic Hepatitis B Patients with Normal or Mildly Elevated ALT.
7/2021	Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet () and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial.
1/2019	Serum miR-21 and miR-26a Levels Negatively Correlate with Severity of Cirrhosis in Patients with Chronic Hepatitis B.
1/2017	High serum resistin associates with intrahepatic inflammation and necrosis: an index of disease severity for patients with chronic HBV infection.
4/2015	Efficacy of telbivudine in the treatment of chronic hepatitis b and liver cirrhosis and its effect on immunological responses.
1/2013	Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism.
10/2012	Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Liu Research Topics

Disease

364	Neoplasms (Cancer) 04/2024 - 06/2002
110	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 06/2000
101	Inflammation (Inflammations) 03/2024 - 09/2004
97	Fibrosis (Cirrhosis) 03/2024 - 08/2002
76	Infections 03/2024 - 08/2004
59	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 08/2008
50	Neoplasm Metastasis (Metastasis) 01/2024 - 07/2002
44	Body Weight (Weight, Body) 04/2023 - 03/2006
42	Stomach Neoplasms (Stomach Cancer) 01/2023 - 08/2004
37	Cataract (Cataracts) 01/2023 - 08/2006
34	Carcinogenesis 01/2024 - 08/2004
33	Breast Neoplasms (Breast Cancer) 10/2023 - 03/2008
32	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 09/2009
31	Carcinoma (Carcinomatosis) 10/2023 - 11/2005
28	Liver Diseases (Liver Disease) 05/2024 - 11/2004
28	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 04/2009
25	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2006
25	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 06/2007
25	Leukemia 01/2023 - 08/2006
23	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 07/2002
23	Hypoxia (Hypoxemia) 12/2023 - 10/2004
22	Wounds and Injuries (Trauma) 04/2024 - 06/2005
22	Ischemic Stroke 03/2024 - 07/2011
21	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 09/2011
20	Pain (Aches) 03/2024 - 12/2006
20	COVID-19 02/2024 - 01/2020
18	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 08/2014
18	Ischemia 01/2022 - 07/2006
17	Atherosclerosis 04/2024 - 03/2011
17	Non-alcoholic Fatty Liver Disease 10/2023 - 11/2008
17	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 07/2014
17	Melanoma (Melanoma, Malignant) 11/2022 - 08/2008
16	Chronic Hepatitis B 01/2024 - 08/2002
16	Stroke (Strokes) 03/2023 - 01/2016
16	Brain Ischemia (Cerebral Ischemia) 01/2023 - 07/2006
15	Obesity 01/2023 - 06/2007
15	Cognitive Dysfunction 01/2023 - 09/2013
14	Adenocarcinoma of Lung 06/2023 - 01/2011
13	Reperfusion Injury 02/2024 - 07/2006
13	Disease Progression 01/2023 - 10/2006
13	Necrosis 09/2019 - 10/2007
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2024 - 01/2016
12	Colonic Neoplasms (Colon Cancer) 04/2024 - 01/2015
12	Brain Injuries (Brain Injury) 03/2024 - 10/2007
12	Osteosarcoma (Osteogenic Sarcoma) 03/2022 - 03/2013
12	Hepatitis B 08/2019 - 07/2002
11	Dysbiosis 02/2024 - 04/2019
11	Adenocarcinoma 01/2024 - 01/2013
11	Insulin Resistance 04/2023 - 01/2003
11	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 04/2010

Drug/Important Bio-Agent (IBA)

168	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2003
98	Biomarkers (Surrogate Marker)IBA 07/2024 - 08/2007
95	MicroRNAs (MicroRNA)IBA 11/2023 - 04/2009
59	Messenger RNA (mRNA)IBA 03/2024 - 06/2000
50	Therapeutic UsesIBA 04/2024 - 11/2004
38	CytokinesIBA 02/2024 - 10/2003
33	CollagenIBA 03/2024 - 06/2000
32	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2023 - 12/2004
28	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 11/2006
28	LipidsIBA 02/2024 - 11/2006
28	Dimethylnitrosamine (Nitrosodimethylamine)IBA 12/2023 - 10/2003
27	fuzheng huayuIBA 03/2024 - 07/2003
27	AntioxidantsIBA 10/2023 - 10/2007
26	DNA (Deoxyribonucleic Acid)IBA 05/2023 - 07/2002
25	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 12/2010
25	Antiviral Agents (Antivirals)IBA 11/2023 - 11/2009
21	EnzymesIBA 03/2024 - 03/2007
21	Interleukin-6 (Interleukin 6)IBA 03/2024 - 10/2003
20	Long Noncoding RNAIBA 01/2024 - 12/2016
20	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2004
19	Capsules (Microcapsules)IBA 01/2024 - 07/2003
17	SolutionsIBA 04/2024 - 03/2006
17	Bile Acids and Salts (Bile Acids)IBA 08/2023 - 07/2011
17	LipopolysaccharidesIBA 01/2023 - 02/2010
17	Peptides (Polypeptides)IBA 10/2022 - 03/2007
16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 12/2005
16	Transcription Factors (Transcription Factor)IBA 01/2023 - 07/2002
16	huangqi decoctionIBA 04/2021 - 04/2006
15	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 12/2011
15	Phosphotransferases (Kinase)IBA 10/2023 - 02/2008
14	Caspase 3 (Caspase-3)IBA 03/2024 - 01/2011
14	VaccinesIBA 11/2023 - 01/2009
14	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 01/2011
13	CholesterolIBA 04/2023 - 11/2006
13	Arginine (L-Arginine)FDA Link 02/2023 - 10/2011
13	ErbB Receptors (EGF Receptor)IBA 12/2021 - 11/2009
12	Indicators and Reagents (Reagents)IBA 03/2023 - 02/2008
12	AntigensIBA 03/2022 - 12/2004
11	Tyrosine Kinase InhibitorsIBA 03/2024 - 11/2009
11	Troleandomycin (TAO)FDA Link 11/2023 - 11/2020
11	ProteomeIBA 01/2023 - 03/2006

Therapy/Procedure

196	Therapeutics 04/2024 - 07/2003
57	Drug Therapy (Chemotherapy) 12/2023 - 11/2002
50	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2024 - 11/2004
43	Hysterectomy 01/2024 - 10/2006
27	Immunotherapy 11/2023 - 07/2014
21	Aftercare (After-Treatment) 01/2024 - 02/2002
16	Radiotherapy 09/2023 - 02/2004
14	Neoadjuvant Therapy 04/2024 - 04/2010
14	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 10/2006